Quick Asked: Synthekine Contact Us?
Last update: 27 Apr, 2024 
111 Views
What does synthekine do? The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. Using the principles of cytokine partial agonism and immunological specificity, Synthekine designs differentiated therapeutics to be both safe and efficacious.Who is the head of therapeutic discovery at synthekine? Rob has served as Synthekine’s Head of Therapeutic Discovery since the company’s formation in 2019 and is a long-time collaborator of Synthekine founder, Christopher Garcia, Ph.D. Prior to Synthekine, Rob led a team at Merck that was responsible for building the company’s discovery portfolio of cancer immunotherapies.What is synthekine immunotherapy? The company anticipates filing an IND in 2021 for this potent immunotherapy. Synthekines are agonists that can combine cytokine receptors and drive new signaling activities without any reliance on the wild-type cytokine.What is synthekines il 2 partial agonist stk 012? Designed to selectively agonize cancer antigen activated T cells, Synthekine’s lead immuno-oncology IL-2 partial agonist, STK-012, has demonstrated single-agent activity in preclinical tumor models. The company anticipates filing an IND in 2021 for this potent immunotherapy.
Listing Results Synthekine Contact Us? Question Answers
Synthekine Overview, News & Competitors ...
(650) 271-9888 Synthekine’s headquarters are in 1505 O'Brien Dr, Menlo Park, California, 94025, United States What is Synthekine’s phone number? Synthekine’s phone number is (650) 271-9888
A longtime CytomX exec reemerges at Synthekine, an $82M
Debanjan Ray apparently had big plans when he quietly left his long-held CFO spot at CytomX back in March 2019. He had gotten his own biotech. Still in its early stages at the time, that biotech, known as Synthekine, is now ready to start talking. They are breaking out of stealth mode today with $82 million in Series A funding led by Canaan Partners, Samsara BioCapital ...